Wuhan Hiteck Biological Pharma Co.,Ltd. Posted 7.9 Million Yuan Net Loss in 2022

Wuhan Hiteck Biological Pharma Co.,Ltd. (武汉海特生物制药股份有限公司) (300683.SZ) reported a net loss of 7.9 million yuan in 2022, reversing a net profit of 30 million yuan for the previous year.

Meanwhile, the company posted 688.6 million yuan in revenue, up 12% year-on-year.

At the end of the reporting period, it had 2.7 billion yuan in total assets and 371.2 million yuan in total liabilities, with a liability-to-asset ratio of 13.7%.